ADMA
ADMA Biologics, Inc.
NASDAQ · USHealthcareBiotechnology
$8.75+0.46%
Price as of Jul 20, 2026
ADMA valuation
ADMA Biologics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 8.41x
- P/E 2026E
- 9.14x
- P/E 2027E
- 6.84x
- P/E 2028E
- 5.40x
- P/S forward
- 2.90x
Trailing multiples
- P/E TTM
- 12.68x
- PEG TTM
- 0.25x
- Price / book
- 5.20x
- Price / sales
- 3.98x
- Price / cash flow
- 15.80x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 4.11x
- EV / EBITDA
- 9.45x
- EV / EBIT
- 10.12x
- Market cap
- $2.0B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.